Key Insights

Highlights

Success Rate

67% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 47/100

Termination Rate

18.8%

3 terminated out of 16 trials

Success Rate

66.7%

-19.8% vs benchmark

Late-Stage Pipeline

6%

1 trials in Phase 3/4

Results Transparency

67%

4 of 6 completed with results

Key Signals

4 with results67% success

Data Visualizations

Phase Distribution

14Total
Not Applicable (2)
P 1 (7)
P 2 (4)
P 3 (1)

Trial Status

Completed6
Recruiting3
Terminated3
Active Not Recruiting2
Suspended1
Withdrawn1

Trial Success Rate

66.7%

Benchmark: 86.5%

Based on 6 completed trials

Clinical Trials (16)

Showing 16 of 16 trials
NCT05440786Phase 2Active Not RecruitingPrimary

CAMPFIRE: A Study of Abemaciclib (LY2835219) in Participants With Ewing's Sarcoma

NCT05046314Phase 2CompletedPrimary

A Clinical Study of TK216 in Patients With Relapsed or Refractory Ewing's Sarcoma

NCT04890093Phase 1SuspendedPrimary

Vincristine and Temozolomide in Combination With PEN-866 for Adolescents and Young Adults With Relapsed or Refractory Solid Tumors

NCT06709495Phase 1Recruiting

Phase 1/2 Trial to Evaluate the Safety and Efficacy of PEEL-224 in Combination With Vincristine and Temozolomide in Adolescents and Young Adults With Relapsed or Refractory Sarcomas

NCT06387485Not ApplicableRecruitingPrimary

A Study to Evaluate the Utilization of 3D Printed Models in Pre-Operative Planning

NCT02415816Not ApplicableCompleted

Diffusion Weighted Magnetic Resonance in Imaging Younger Patients With Newly Diagnosed Bone or Soft Tissue Sarcomas

NCT07066982Phase 1Recruiting

Sequential Infusion of CD146-Targeted and HER2-Targeted CAR T Cells in Patients With Advanced Sarcomas

NCT05772312CompletedPrimary

Quality of Life of Patients With Bone Tumor of the Lower Limbs Treated With Salvage Surgery

NCT03778996Phase 2Active Not RecruitingPrimary

SM-88 Maintenance Therapy for Advanced Ewing's Sarcoma and as Salvage Therapy for Sarcoma

NCT02657005Phase 1TerminatedPrimary

TK216 in Patients With Relapsed or Refractory Ewing Sarcoma

NCT01661400Phase 1Completed

Anti-Angiogenic Therapy Post Transplant (ASCR) for Pediatric Solid Tumors

NCT05100368CompletedPrimary

The Prognostic Value of Serum Biomarkers in Ewing's Sarcoma

NCT03495921Phase 3Terminated

A Trial For Participants With Ewing's Sarcoma Treated With Vigil in Combination With Irinotecan and Temozolomide

NCT03275818Phase 2Completed

Trial of Nab-paclitaxel in Patients With Desmoid Tumors and Multiply Relapsed/Refractory Desmoplastic Small Round Cell Tumors and Ewing Sarcoma

NCT02581384Phase 1Terminated

Stereotactic Body Radiotherapy (SBRT) for Pulmonary Metastases in Ewing Sarcoma, Rhabdomyosarcoma, and Wilms Tumors

NCT02557854Phase 1Withdrawn

HIFU Hyperthermia With Liposomal Doxorubicin (DOXIL) for Relapsed or Refractory Pediatric and Young Adult Solid Tumors

Showing all 16 trials

Research Network

Activity Timeline